LifeStance Health Group (NASDAQ:LFST) Stock: Insider Lisa Miller Sells 14,663 Shares

LifeStance Health Group, Inc. (NASDAQ:LFST) COO Lisa Miller sold 14,663 shares of the stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $14.68, for a total value of $215,252.84. Following the sale, the chief operating officer directly owned 251,904 shares of the company’s stock, valued at $3,697,950.72. The trade was a 5.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

LifeStance Health Group Stock Performance

Shares of NASDAQ:LFST traded down $0.07 during trading on Friday, reaching $14.08. The company had a trading volume of 3,728,905 shares, compared to its average volume of 6,598,220. LifeStance Health Group, Inc. has a fifty-two week low of $6.01 and a fifty-two week high of $15.66. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.44 and a quick ratio of 1.44. The stock’s fifty day moving average price is $12.79 and its 200 day moving average price is $9.67. The firm has a market capitalization of $5.35 billion, a price-to-earnings ratio of 74.11 and a beta of 1.35.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. LifeStance Health Group had a return on equity of 4.82% and a net margin of 4.29%. The firm had revenue of $455.86 million during the quarter, compared to the consensus estimate of $431.59 million. LifeStance Health Group’s quarterly revenue was up 25.3% on a year-over-year basis. As a group, equities research analysts predict that LifeStance Health Group, Inc. will post 0.18 EPS for the current year.

Wall Street Analyst Weigh In

LFST has been the subject of several recent analyst reports. Barclays raised their target price on shares of LifeStance Health Group from $13.00 to $15.00 and gave the stock an “overweight” rating in a research note on Thursday, September 10th. JPMorgan Chase & Co. boosted their price target on shares of LifeStance Health Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Thursday. KeyCorp increased their price target on shares of LifeStance Health Group from $15.00 to $17.00 and gave the stock an “overweight” rating in a report on Friday, November 6th. Canaccord Genuity Group raised their price objective on shares of LifeStance Health Group from $15.00 to $16.00 and gave the company a “buy” rating in a research report on Friday, November 6th. Finally, Wall Street Zen upgraded shares of LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, LifeStance Health Group currently has an average rating of “Moderate Buy” and an average price target of $14.86.

Institutional Investors Weigh In On LifeStance Health Group

Institutional investors have recently made changes to their positions in the stock. Capstone Investment Advisors LLC purchased a new position in LifeStance Health Group in the 2nd quarter valued at approximately $554,000. Bank of America Corp DE acquired a new position in LifeStance Health Group during the second quarter worth $14,987,000. Summit Creek Advisors LLC acquired a new position in LifeStance Health Group during the third quarter worth $2,408,000. WINTON GROUP Ltd boosted its position in LifeStance Health Group by 522.3% during the second quarter. WINTON GROUP Ltd now owns 186,589 shares of the company’s stock worth $1,998,000 after purchasing an additional 156,607 shares in the last quarter. Finally, Squarepoint Ops LLC purchased a new stake in LifeStance Health Group during the second quarter worth $1,283,000. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc. is a U.S. provider of outpatient mental health services. The company offers care through in-person clinics and virtual appointments, connecting patients with behavioral health professionals. Its services include psychotherapy, psychiatric evaluations and medication management. LifeStance’s clinicians treat a range of mental health conditions, including anxiety, depression, attention-deficit/hyperactivity disorder and mood disorders. Founded in 2017, LifeStance has expanded its network across the United States.